These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15655325)

  • 21. The new standard of fluids for hemodialysis in Japan.
    Kawanishi H; Masakane I; Tomo T
    Blood Purif; 2009; 27 Suppl 1():5-10. PubMed ID: 19556756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sterile versus non-sterile dialysis fluid in chronic hemodialysis treatment.
    Bambauer R; Meyer S; Jung H; Goehl H; Nystrand R
    ASAIO Trans; 1990; 36(3):M317-20. PubMed ID: 2252688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients.
    Lornoy W; De Meester J; Becaus I; Billiouw JM; Van Malderen PA; Van Pottelberge M
    J Ren Nutr; 2006 Jan; 16(1):47-53. PubMed ID: 16414441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dialysis water as a determinant of the adequacy of dialysis.
    Ward RA
    Semin Nephrol; 2005 Mar; 25(2):102-11. PubMed ID: 15791562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dialysate quality: new standards require a new approach to compliance.
    Fendley DA; Ward RA
    Semin Dial; 2012; 25(5):510-5. PubMed ID: 22994601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The concept of ultrapure solution online production].
    Pacitti A
    G Ital Nefrol; 2008; 25 Suppl 41():S28-32, discussion S33-44. PubMed ID: 18473318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study.
    Hsu PY; Lin CL; Yu CC; Chien CC; Hsiau TG; Sun TH; Huang LM; Yang CW
    J Nephrol; 2004; 17(5):693-700. PubMed ID: 15593037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The early years of on-line HDF: how did it all start? How did we get here?
    Canaud B
    Contrib Nephrol; 2011; 175():93-109. PubMed ID: 22188692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review: Clinical usefulness of ultrapure dialysate--recent evidence and perspectives.
    Masakane I
    Ther Apher Dial; 2006 Aug; 10(4):348-54. PubMed ID: 16911188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should ultrapure dialysate be part of standard therapy in hemodialysis?
    Canaud B; Granger-Vallée A
    Semin Dial; 2011; 24(4):426-7. PubMed ID: 21801232
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.
    Lonnemann G; Bechstein M; Linnenweber S; Burg M; Koch KM
    Kidney Int Suppl; 1999 Nov; (72):S84-7. PubMed ID: 10560813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Extrarenal elimination procedures in acute kidney failure].
    Sold M
    Anaesthesist; 1990 Nov; 39(11):569-86. PubMed ID: 2288406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification of dialysis water in the central dialysis fluid delivery system in Japan: a prospective observation study.
    Uchino J; Kawasaki T
    Blood Purif; 2009; 27 Suppl 1():64-9. PubMed ID: 19556766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endotoxemia after high cutoff hemodialysis for treatment of patient with multiple myeloma can be prevented by using ultrapure dialysate: a case report.
    Gong D; Ji D; Zhang K; Huang X; Huang G; Xu B; Liu Z
    Hemodial Int; 2013 Oct; 17(4):618-23. PubMed ID: 23113894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How do changes in water quality and dialysate composition affect clinical outcomes?
    Hoenich NA; Levin R; Ronco C
    Blood Purif; 2009; 27(1):11-5. PubMed ID: 19169011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AAMI releases new standards for dialysate for hemodialysis.
    Curtis J
    Nephrol News Issues; 2004 Dec; 18(13):54-6. PubMed ID: 15643823
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of using ultrapure dialysate for hemodialysis on the level of circulating bacterial fragment in renal failure patients.
    Kwan BC; Chow KM; Ma TK; Cheng PM; Leung CB; Li PK; Szeto CC
    Nephron Clin Pract; 2013; 123(3-4):246-53. PubMed ID: 24008429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Guidelines for quality management of dialysis solutions].
    Pérez García R; González Parra E; Ceballos F; Escallada Cotero R; Gómez-Reino MI; Martín-Rabadán P; Pérez García A; Ramírez Chamond R; Sobrino PE; Solozábal C;
    Nefrologia; 2004; 24 Suppl 2():1-42. PubMed ID: 15083969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Factors which influence phosphorus removal in hemodialysis].
    Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
    Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetate free biofiltration. Effects on peripheral blood monocyte activation and cytokine release.
    Carozzi S; Nasini MG; Caviglia PM; Schelotto C; Santoni O; Atti M
    ASAIO J; 1992; 38(1):52-4. PubMed ID: 1313318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.